Diagnostic Imaging

Radiologists use diagnostic imaging to non-invasively look inside the body to help determine the causes of an injury or an illness, and confirm a diagnosis. Providers use many imaging modalities to do so, including CT, MRI, X-ray, Ultrasound, PET and more.

RSS icon
Thumbnail

Top MRI trends include helium-free systems, compressed sensing and AI

Signify Research outlines several key technologies and trends in MRI to look for at the Radiological Society of North America 2022 meeting.

New DL model detects effects of long COVID using only x-rays

The model could be beneficial for long COVID patients in areas where CT scans are not readily available, researchers concluded.

A GE Revolution CT system on display at the 2022 Society of cardiovascular Computed Tomography (SCCT) meeting is an example of the types of the systems being sought in the U.S. and Western Europe replacement CT market. It features AI enhanced features to automate protocol and help reduce dose, 160 mm of anatomical coverage per rotation and offers spectral imaging using fast kV switching between different energies during one scan.

Trends and new technology in computed tomography systems

Leading up to the 2022 RSNA meeting, Signify Research shares the trends and new innovations in CT scanner technology it has seen in recent years.

Advances in computed tomography scanner (CT) technology include photon-counting (Siemens image left) and faster, higher slice CT systems with integrated AI. Right image is GE Healthcare's Revolution on display at SCCT 2022. Trends in CT imaging by Signify Research.

VIDEO: CT imaging market trends and advances overview by Signify Research

Bhvita Jani, research manager, Signify Research, explains key trends and technology advances in the computed tomography (CT) market. 

Ricardo Cury, MD, MBA, MSCCT, chairman of radiology, direct of cardiac imaging, Baptist Health South Florida and Miami Cardiac and Vascular Institute, discusses the new CAD-RADS 2.0 cardiac imaging reporting criteria at the 2022 SCCT meeting. Interview with Radiology Business Editor Dave Fornell.

VIDEO: What is new with CAD-RADS 2.0 cardiac imaging reporting?

Ricardo Cury, MD, chairman of radiology and director of cardiac imaging, Baptist Health South Florida and Miami Cardiac and Vascular Institute, discusses the new CAD-RADS 2.0 cardiac imaging reporting criteria.

Contrast-enhanced mammography uses iodine contrast injected into a patient and mammography system to image contrast uptake or areas of increased vascular activity, which is typical of cancers. This can help image through dense breast tissue to find cancers that are otherwise masked by dense breast tissue.

VIDEO: Why contrast enhance mammography might be the ideal supplemental imaging

Connie Lehman, MD, PhD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at the Massachusetts General Hospital, explains why she thinks contrast-enhanced mammography will likely become the go-to supplemental imaging modality for women with dense breasts.

Thumbnail

AI software's pediatric fracture detection in line with that of radiologists

An artificial intelligence system that is currently commercially available for use in adults could also have applications in a pediatric population, according to a new study in Pediatric Radiology.

Illustration of the four types of breast tissue densities. The more dense, the harder it is for radiologists to detect cancers, which had led to about 40 states to now require notiofication of patients if they have dense breasts and the impact on their care, with possible miss-reads and that they may need supplemental imaging.

VIDEO: What is the impact of breast density notification laws?

Society of Breast Imaging (SBI) President John Lewin, MD, discusses how legislation concerning breast density notifications has impacted mammography.

Displaying 25 - 32 of 648

Around the web

Cardiovascular Business
'This could be a paradigm shift': How PET with newly approved flurpiridaz compares to SPECT

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Cardiovascular Business
Ultrafast myocardial contrast echocardiography shows early potential to evaluate CAD

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Cardiovascular Business
FDA clears new software for AI-powered CCTA assessments

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Design by Adaptive Theme
Trimed Popup
Trimed Popup